These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24766655)

  • 1. Comparative study between synthetic and phospholipids of natural origin: effect of phospholipid selection on the behavior of a topical liposomal dosage form incorporating terbinafine.
    Koutsoulas C; Suleiman E; Wagner A; Žabka M
    J Liposome Res; 2014 Dec; 24(4):336-43. PubMed ID: 24766655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of liposomal nanoparticles incorporating terbinafine in vitro drug release studies.
    Koutsoulas C; Pippa N; Demetzos C; Zabka M
    J Nanosci Nanotechnol; 2014 Jun; 14(6):4529-33. PubMed ID: 24738424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
    Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
    Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of topical hydrogels of terbinafine hydrochloride and evaluation of their antifungal activity.
    Çelebi N; Ermiş S; Özkan S
    Drug Dev Ind Pharm; 2015 Apr; 41(4):631-9. PubMed ID: 24576265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, characterization and ex vivo studies of terbinafine HCl liposomes for cutaneous delivery.
    Sudhakar B; Varma JN; Murthy KV
    Curr Drug Deliv; 2014; 11(4):521-30. PubMed ID: 24410098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical antifungal bigels: Formulation, characterization and evaluation.
    Mazurkeviciute A; Ramanauskiene K; Ivaskiene M; Grigonis A; Briedis V
    Acta Pharm; 2018 Jun; 68(2):223-233. PubMed ID: 29702483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan hydrogel with terbinafine--an evaluation of drug release.
    Matusová D; Vitková Z; Truplová E; Herdová P
    Pharmazie; 2010 Jul; 65(7):523-4. PubMed ID: 20662323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
    Padamwar MN; Pokharkar VB
    Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrity of liposomes in presence of various formulation excipients, when dispersed in aqueous media and in hydrogels.
    Mourtas S; Duraj S; Fotopoulou S; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):270-6. PubMed ID: 17928204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulated release of cholesterol from liposomal membranes by a PEGylated phospholipid.
    Janout V; Daly TA; Cline LL; Kulp LJ; Regen SL
    Bioconjug Chem; 2012 Mar; 23(3):336-9. PubMed ID: 22372891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of terbinafine hydrochloride in an extemporaneously prepared oral suspension at 25 and 4 degrees C.
    Abdel-Rahman SM; Nahata MC
    Am J Health Syst Pharm; 1999 Feb; 56(3):243-5. PubMed ID: 10030510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
    Bhatia A; Kumar R; Katare OP
    J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced topical delivery of terbinafine hydrochloride with chitosan hydrogels.
    Ozcan I; Abaci O; Uztan AH; Aksu B; Boyacioğlu H; Güneri T; Ozer O
    AAPS PharmSciTech; 2009; 10(3):1024-31. PubMed ID: 19662536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits.
    Tayel SA; El-Nabarawi MA; Tadros MI; Abd-Elsalam WH
    Int J Pharm; 2013 Feb; 443(1-2):293-305. PubMed ID: 23333217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adsorption, partition and release balances of terbinafine hydrochloride, part I.
    Oremusová J; Vitková Z
    Pharmazie; 2007 Apr; 62(4):273-7. PubMed ID: 17484282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
    Alipour M; Halwani M; Omri A; Suntres ZE
    Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome, gel and lipogelosome formulations containing sodium hyaluronate.
    Duman G; Aslan İ; Özer AY; İnanç İ; Taralp A
    J Liposome Res; 2014 Dec; 24(4):259-69. PubMed ID: 24724824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
    Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
    Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UV-curable gel formulations: Potential drug carriers for the topical treatment of nail diseases.
    Kerai LV; Hilton S; Murdan S
    Int J Pharm; 2015 Aug; 492(1-2):177-90. PubMed ID: 26187167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release of antifungal drug terbinafine hydrochloride from poly(N-vinyl 2-pyrrolidone/itaconic acid) hydrogels.
    Sen M; Yakar A
    Int J Pharm; 2001 Oct; 228(1-2):33-41. PubMed ID: 11576766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.